Biocryst Pharmaceuticals buy Bank of America Co.
Start price
01.07.25
/
50%
€7.65
Target price
01.07.26
€12.73
Performance (%)
-0.89%
Price
07.05.26
€7.58
Summary
This prediction is currently active. Since the start of the prediction for Biocryst Pharmaceuticals the price has only changed by -0.89%. This prediction currently runs until 01.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -2.919% | -2.919% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat